Page 150 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk

CHAPTER 7
14. Berrios-Rivera JP, Street RL, Jr., Garcia Popa-Lisseanu MG, Kallen MA, Richardson MN, Janssen NM, et al. Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 2006 15;55:385-93.
15. Dobkin PL, Sita A, Sewitch MJ. Predictors of adherence to treatment in women with fibromyalgia. Clin J Pain 2006;22:286-94.
16. JacksonCA,ClatworthyJ,RobinsonA,HorneR.Factorsassociatedwithnon-adherenceto oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol 2010;105:525-39.
17. Starfield B, Wray C, Hess K, Gross R, Birk PS, D’Lugoff BC. The influence of patient- practitioner agreement on outcome of care. Am J Public Health 1981;71:127-31.
18. LoflandJH,JohnsonPT,InghamMP,RosemasSC,WhiteJC,EllisL.Shareddecision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs. Patient Prefer Adherence 2017;11:947-58.
19. Stacey D, Legare F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2017;4:CD001431.
20. VeilleuxS,NoiseuxI,LachapelleN,KohenR,VachonL,GuayBW,etal.Patients’perception of their involvement in shared treatment decision making: Key factors in the treatment of inflammatory bowel disease. Patient Educ Couns 2017.
21. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
22. FelsonDT,SmolenJS,WellsG,ZhangB,vanTuylLH,FunovitsJ,etal.AmericanCollegeof Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 2011;70:404-13.
23. van Gestel AM, Prevoo ML, van ‘t Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34-40.
24. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-8.
25. denUD,terWM,BoersM,KerstensP,VoskuylA,NurmohamedM,etal.Anon-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks. Ann Rheum Dis 2014;73:1071-8.
26. Gossec L, Paternotte S, Aanerud GJ, Balanescu A, Boumpas DT, Carmona L, et al. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient- derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann Rheum Dis 2011;70:935-42.
148